CapsoVision (CV) Finished Goods (2024 - 2026)
CapsoVision (CV) posted Finished Goods of $107000.0 for Q4 2025, up 64.62% sequentially from $65000.0 in Q3 2025, and down 39.2% YoY from $176000.0 in Q4 2024.
CapsoVision (CV) Finished Goods (2024 - 2026) Analysis & Trends
CapsoVision has reported Finished Goods for 2 years, with the latest figure at $107000.0 in Q4 2025.
- Quarterly Finished Goods fell 39.2% year-over-year to $107000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $107000.0 (down 39.2% YoY) and the FY2025 annual result came in at $107000.0, down 39.2% from the prior year.
- Finished Goods grew to $107000.0 in Q4 2025 per CV's latest filing, from $65000.0 in the prior quarter.
- Over five years, Finished Goods peaked at $176000.0 in Q4 2024 and troughed at $65000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 162,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 94,000.00 |
| Dec 31, 2024 | 176,000.00 |